Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Sharps Technology, Inc. (STSS : NSDQ)

• Company Description    Sharps Technology Inc. is a medical device company offering patented, best-in-class, single use smart safety syringe products. Sharps Technology Inc. is based in NEW YORK. Number of Employees: 55

• Price / Volume Information    Yesterday's Closing Price: $5.87 Daily Weekly Monthly 20 Day Moving Average: 143,408 shares Shares Outstanding: 1.02 (millions) Market Capitalization: $5.98 (millions) Beta: 2.15 52 Week High: $2,224.20 52 Week Low: $3.36 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.34% -4.07% 12 Week -39.47% -49.08% Year To Date -99.06% -99.12%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 105 MAXESS ROAD STE. 124 - MELVILLE,NY 11747 USA ph: 631-574-4436 fax: - ir@sharpstechnology.com https://sharpstechnology.com

• General Corporate Information    Officers Robert M. Hayes - Chief Executive Officer Soren Bo Christiansen - Chairman Andrew R. Crescenzo - Chief Financial Officer Paul K. Danner - Director Timothy J. Ruemler - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 82003F309 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 1.02 Most Recent Split Date: 4.00 (0.00:1) Beta: 2.15 Market Capitalization: $5.98 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.28 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 111.60% vs. Previous Quarter: 104.44% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -98.77 12/31/24 - -164.66 ROA 06/30/25 - - 03/31/25 - -53.85 12/31/24 - -97.07 Current Ratio 06/30/25 - - 03/31/25 - 1.65 12/31/24 - 0.61 Quick Ratio 06/30/25 - - 03/31/25 - 1.41 12/31/24 - 0.25 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 188.03 12/31/24 - 110.01 Inventory Turnover 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©